By 2028, Global Demand for Tissue Nano Transfection Market Will Surpass USD 7.06 Billion at 16.6% CAGR Growth: Says Vantage Market Research

NEXT STORY
Tarsus Medical Group Officially Announces Rebrand of South Beach Symposium to LiVDerm
PREV STORY
FINN Partners Continues Expansion of its Omni-Channel Platform with Addition of Medika.Life
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics Receives a €10 Million Payment Corresponding to the First Tranche of the Financing Granted by the European Investment Bank

author_avatar
NASDAQ Market News

Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine to Emergency Healthcare Providers and Hospital Staff to Protect Against Hepatitis B Infections Amidst COVID-19 Pandemic

author_avatar
NASDAQ Market News

New SPINRAZA® (nusinersen) Data Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy

NURTURE study participants were alive and did not require permanent ventilation, in contrast to ...

author_avatar
NASDAQ Market News